227 related articles for article (PubMed ID: 3016966)
21. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
[TBL] [Abstract][Full Text] [Related]
22. [Value of computerized tomography in detection of lymph node metastases in bladder cancer].
Buszello H; Müller-Mattheis V; Ackermann R
Urologe A; 1994 May; 33(3):243-6. PubMed ID: 8053093
[TBL] [Abstract][Full Text] [Related]
23. The role of postchemotherapy surgery in managing metastatic germ cell tumors.
Beck SD
Cancer; 2007 Dec; 110(12):2601-3, i. PubMed ID: 17948907
[No Abstract] [Full Text] [Related]
24. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
25. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
26. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
Sexton WJ; Wood CG; Kim R; Pisters LL
J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
[TBL] [Abstract][Full Text] [Related]
27. Overview: treatment of local regional disease.
Donohue JP
Prog Clin Biol Res; 1990; 350():283-93. PubMed ID: 2166958
[No Abstract] [Full Text] [Related]
28. Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.
Hudolin T; Kastelan Z; Knezevic N; Goluza E; Tomas D; Coric M
Int J Surg Pathol; 2012 Feb; 20(1):15-8. PubMed ID: 22180527
[TBL] [Abstract][Full Text] [Related]
29. Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcome.
Tanaka T; Kitamura H; Kunishima Y; Takahashi S; Takahashi A; Masumori N; Itoh N; Tsukamoto T
Jpn J Clin Oncol; 2006 Jun; 36(6):381-6. PubMed ID: 16762970
[TBL] [Abstract][Full Text] [Related]
30. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
31. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of clinical and histopathologic diagnosis for early stages of advanced nonseminomatous germ cell testicular tumors].
Sosnowski M; Płuzańska A; Chmielowski M; Dowgier-Witczak I; Jeromir L
Pol Merkur Lekarski; 1997 Apr; 2(10):273-6. PubMed ID: 9377665
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
[TBL] [Abstract][Full Text] [Related]
35. [Retroperitoneal lymph node recurrence of seminoma 6 years after high orchiectomy].
Yamaguchi Y; Kakimoto K; Ono Y; Norio M; Maeda O; Kinouchi T; Usami M
Hinyokika Kiyo; 2005 Dec; 51(12):835-7. PubMed ID: 16440735
[TBL] [Abstract][Full Text] [Related]
36. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
37. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
Lowe BA
Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
[TBL] [Abstract][Full Text] [Related]
38. Editorial comment.
Lin DW
J Urol; 2009 Dec; 182(6):2720. PubMed ID: 19836765
[No Abstract] [Full Text] [Related]
39. Laparoscopic approach to retroperitoneal lymph node dissection.
Gerber GS; Rukstalis DB
Semin Surg Oncol; 1996; 12(2):121-5. PubMed ID: 8685577
[TBL] [Abstract][Full Text] [Related]
40. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
